FDA Medicare study in 134,000 atrial fibrillation patients confirms positive safety profile and effectiveness of Pradaxa < sup > ® < /sup > in general practice
FDA Medicare study in 134,000 atrial fibrillation patients confirms positive safety profile and effectiveness of Pradaxa < sup > ® < /sup > in general practice
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news
More News: Atrial Fibrillation | General Practices | Medicare | Pradaxa | Primary Care | Research | Study